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Monacolins, as natural statins, form a class of fungal secondary metabolites and act as the speciﬁc inhibitors of HMG-
CoA reductase. The interest in using the fermented products as the natural source of monacolins, instead of statin drugs, is
increasing enormously with its increasing demand. In this study, the fermented products were produced by Monascus purpureus
FTC5391 using submerged and solid state fermentations. Two commercial Monascus-fermented products were also evaluated for
comparison. Improved methods of monacolins extraction and identiﬁcation were developed for the assessment of monacolins in
thefermentedproducts.Methanolandethanolwerefoundtobethemostfavorablesolventsformonacolinsextractionduetotheir
ability to extract higher amount of monacolin K and higher numbers of monacolin derivatives. Problem related to false-positive
results during monacolins identiﬁcation was solved by adding monacolin lactonization step in the assessment method. Using this
improved method, monacolin derivatives were not detected in all Monascus-fermented products tested in this study, suggesting
that their hypocholesterolemic eﬀects may be due to other compounds other than monacolins.
1.Introduction
Cardiovascular disease, particularly coronary heart disease
(CHD), is one of the main causes of mortality in developed
countries [1, 2]. Atherosclerosis is the underlying disorder
in the majority of patients presenting cardiovascular disease.
Atherosclerosisisdisplayedwhenfat,cellularwasteproducts,
calcium, and other substances, particularly cholesterol, are
deposited inside the artery, gradually reducing the inside
diameter of the artery. Subsequently, this may cause blockage
of large- and medium-sized arteries [1, 3]. Hence, the blood
cholesterol level should be controlled to avoid atherosclero-
sis.Epidemiologicalstudieshavedemonstratedastrongasso-
ciation between plasma cholesterol concentration and risk of
CHD [4]. Statins (in particular, monacolin K, mevinolin, or
lovastatin) form a class of molecules with a polyketide struc-
ture, a well-known inhibitor of HMG-CoA reductase. They
are produced by secondary metabolism of several fungi such
as Aspergillus terreus, Penicillium citrinum, and Monascus
spp. [3]. At present, statins are widely used as hypercholes-
terolemia drugs for reduction of plasma cholesterol level
[5].
Since, the great eﬀect of food on health has been
accepted, utilization of complementary and alternative ther-
apies (natural treatments) for a variety of chronic diseases
are increasing in demand. Red fermented rice or speciﬁcally,
the Monascus-fermented product (MFP), is one of the
popular remedies advertised as a therapy for hyperlipidemia.2 Journal of Biomedicine and Biotechnology
Consumer spending on red yeast rice grew by about 80%
from 2005 to 2008 in the United States, with the total sales of
USD 20 million in 2008 [6, 7]. In Asia, particularly in China,
Taiwan, Japan, and Indonesia, MFPs produced by Monascus
spp. have been used as dietary supplements and remedy for
decades [8, 9].
MFP contains at least 14 major chemical constituents
whichhavechemicalsimilaritytostatin.Itisbelievedthatthe
cholesterol-lowering activity of MFP is mainly due to mona-
colinK(mevinolinorlovastatin).However,theeﬀectofMFP
on blood cholesterol could not be fully explained by the
action of monacolin K alone, instead, it might be the com-
binedeﬀectofmonacolinsandothersubstancesinMFP[10].
Sinceredfermentedricehasnotyetbeenapprovedasmedic-
inal by the Food and Drug Administration (FDA), physicians
may be limited in suggesting the guidelines of using this
productbythepatients.Inthisregard,generationofaccurate
information on the type and amount of monacolins present
in MFP as a natural supplement is a complicated task.
The main objective of this study was to compare the
quality and quantity of monacolins present in MFPs pro-
duced by M. purpureus FTC5391 with two commercial MFPs
available in the market. The fermented products by M. pur-
pureus FTC5391 were prepared using solid and submerged
fermentation techniques with various types of substrate for
enhancement of monacolins synthesis. To maximize the
extraction of monacolins from the MFP, the extraction
parameters such as type of solvent and temperature were
optimized. Some important points for the improvement of
methods for the detection of monacolins present in MFP
were also identiﬁed in this study.
2.MaterialsandMethods
2.1. Materials. MK (mevinolin, lovastatin) standard, triﬂu-
oroacetic acid (TFA) analytical grade, corn steep liquor,
and monosodium glutamate were purchased from Sigma
(St. Louis, Mo, USA). Soybean, groundnut, coconut waste,
gluten, pineapple waste, rice, and rice bran were purchased
from local markets. The red yeast rice (RYR) capsule was
obtained from Cosway (Malaysia), while Hypocol was pur-
chased from Wearnes Biotech and Medicals (Malaysia). Yeast
extract, malt extract, casamino acids, agar, standard Czapek
medium, potato dextrose agar (PDA) and peptone were
purchased from Difco (USA). Other chemicals, including
methanol and acetonitrile (ACN), ethyl acetate, isopropanol,
butanol (HPLC grade), and ethanol (analytical grade) were
obtained from Merck (Germany).
2.2. Preparation of Monascus-Fermented Products. M. pur-
pureus FTC5391 is a red-pigment-producing fungus isolated
from fermented rice (angkak) and maintained at the culture
collection in Malaysian Agricultural Research and Devel-
opment Institute (MARDI). M. purpureus FTC5391 was
maintained after routine inoculation on PDA and incubated
at 30◦C for 7 days, by storage at 4◦C and refreshing monthly.
For inoculum preparation, mycelia blocks (4 × 4mm) of M.
purpureus were transferred into 100mL of YMP (3g/L yeast
extract; 3g/L malt extract; 5g/L peptone; 20g/L glucose) in
a 250mL ﬂask. The ﬂasks were incubated in rotary orbital
shaker at 30◦C, agitated at 150rpm for 4 days, and these cul-
tures were used as a standard inoculum for all fermentations.
The ability of M. purpureus FTC5391 in producing MK
was tested on solid (SSF) and in submerged fermentations
(SmF) using diﬀerent media, including: Hiroi or sucrose
medium [11] (sucrose (100g/L), yeast extract (3g/L),
casamino acids (5g/L), NaNO3 (2g/L), KH2PO4 (1g/L),
MgSO4·7H2O (0.5g/L), KCl (0.5g/L), FeSO4 (0.01g/L),
and agar (15g/L)); Hiroi-PDA (sucrose (100g/L), yeast
extract (3g/L), casamino acid (5g/L), NaNO3 (2g/L),
KH2PO4 (1g/L), MgSO4·7H2O (0.5g/L), KCl (0.5g/L),
FeSO4(0.01g/L), potato starch (4g/L), dextrose (20g/L),
and agar (15g/L)); Hajaj medium [12] (glucose (50g/L),
monosodium glutamate (12g/L), KH2PO4 (2.5g/L),
K2HPO4 (2.5g/L), MgSO4·7H2O (1g/L), K Cl (0.5g/L),
ZnSO4·7H2O (0.001g/L), FeSO4·7H2O (0.001g/L) and
MnSO4·7H2O(0.003g/L));glucose-glycerol-peptone(GGP)
medium[13,14](glucose(30g/L),glycerol(70g/L),peptone
(38g/L), MgSO4·2H2O (1g/L), and NaNO3 (2g/L));
glutenous medium (gluten (40g/L), malt (9g/L), glucose
(30g/L), MnSO4·7H2O( 2g / L ) ,a n dM g S O 4·7H2O (3g/L));
Rice medium (rice (40g/L), malt (9g/L), glucose (30g/L),
MnSO4·7H2O( 2 g / L )a n dM g S O 4·7H2O (3g/L)); and,
glucose-peptone-corn steep liquor (GPC) medium [15, 16]
(glucose (60g/L), peptone (25g/L), corn steep liquor (5g/L)
and NH4Cl (5g/L)).
SmFswerecarriedoutin1000mLErlenmeyerﬂaskscon-
taining 500mL liquid medium. All media were autoclaved
for15minat121◦CafteradjustingthepHat6.0.Glucosewas
autoclavedseparatelytoavoidthecaramelizationprocessand
then was added to the related media under sterile conditions.
The ﬂasks were inoculated with 10% (v/v) inoculum and
incubated in a rotary orbital shaker at diﬀerent temperatures
(25–37◦C)anddiﬀerentagitationrates(110–250rpm)for25
days. Samples (5mL) were withdrawn at 48h intervals for
MK analysis.
SSFs were carried out using diﬀerent solid substrates,
includingsoybean,groundnut,gratedcoconutwaste,gluten,
pineapple waste, rice, and rice bran. The substrates were
ground and mixed with 1% (w/v) acetic acid. The 500mL
beaker containing 200g of substrate was sterilized for
15min at 121◦C. To start the fermentation, the beaker
was inoculated with the standard inoculum (10% v/w) and
incubatedatdiﬀerenttemperatures(25–37◦C)untilthecolor
of media had completely changed to red, normally about 10
days. During the fermentation, the humidity was maintained
at 50–60%.
2.3. Sample Preparation
2.3.1. Extraction Conditions. The following solvents were
used for the extraction process: ethanol, methanol, ethyl
acetate, ACN, isopropanol, ethyl acetate, and butanol. The
extraction was conducted for 30min, 1h, 2h, and 12h at
diﬀerent temperatures (37–80◦C).
ExtractionofMonacolinCompounds. Slightlydiﬀerentmeth-
ods for extraction of monacolins were applied to solid andJournal of Biomedicine and Biotechnology 3
liquid samples of the prepared fermented products. Solid
fermented product was dried and ﬁnely ground into powder.
The sample (0.5g) was mixed with 5mL of ethanol/water
solution (75:25) for 2h at 60◦C under agitation, followed
by centrifugation for 10min at 3000×g. Liquid fermented
product was homogenized to break the mycelia cells. The
homogenizedsample(5mL)wasextractedwith5mLof95%
ethanol for 2h at 60◦C under agitation and was subsequently
centrifuged for 10min at 3000×g. In both cases, the super-
natant (1mL) was concentrated and dried under vacuum
andthenwasresolvedin1mLACN.Themixturewasﬁltered
throughamembraneﬁlter(0.45μm)priortoHPL Canalysis.
2.3.2. Preparation of the Standard Solution. Calibration
curves were obtained using an MK standard. The purity
of the standard was evaluated using LC/PDA. MK (10mg)
was dissolved in pure solvents aforementioned or ethanol in
water (75:25 v/v) inside a 50mL actinic volumetric ﬂask.
The solutions were diluted with solvents to obtain the stan-
dard solutions for the calibration curve in a concentration
ranging from 0.2 to 20ng/mL. Individual solutions were
ﬁltered through a 0.45μm syringe membrane ﬁlter prior to
injection (20μL) into HPLC.
2.3.3. Lactonization. MK has two forms, lactone (MKL)
a n dh y d r o x y la c i d( M K A )f o r m s .F o rl a c t o n i z a t i o no fM K ,
1mL of the extracted supernatant was mixed with 0.1N
NaOH (1mL) and kept for 2h at 30◦C. The mixture was
concentrated and dried under vacuum, which was then
resolved in 1mL ACN. The solution was ﬁltered through
a0 . 4 5 μm membrane syringe ﬁlter prior to analysis using
HPLC.
2.4. Detection of Monacolins. The HPLC system (Waters
2695 Alliance, Waters Inc., USA) was equipped with an on-
line degasser, and an autosampler was used for detection
of monacolin. The raw data were detected by 2996 PDA,
acquiredand processed byaWatersMillennium32/Empower
software, chromatographic workstation loaded on an IBM
computer. The column of Waters Symmetry C18 (150mm ×
3.9mm i.d., 5μm) was used as a stationary phase. A linear
gradient of concentrated ACN (eluent A) and 0.1% TFA
(eluent B) was used as the mobile phase at a ﬂow rate of
0.9mL/min. The amount of eluent A was increased from 5
to 75% in the ﬁrst 15min, kept at 75% for 5min, increased
to 95%, and then reduced to 5% in another 10min. The
PDA was used at absorbance ranging from 210 to 350nm.
The column temperature was set at 28◦C, and the injection
volume was 20μL.
The Thermo-Finnigan LCQ Classic was employed to
analyze separation via liquid chromatography, coupled
with electrospray ionization (ESI) quadrupole ion-trap
mass spectrometry. The chromatographic conditions of
LC/PDA/MS were modiﬁed from the conditions of LC/PDA.
The separations by LC/PDA/MS were performed using an
arrow-bore reversed-phase Zorbax SB-C18 HPLC column
(2.1mm × 100mm i.d., 5μm, Agilent Scientiﬁc, Calif, USA)
with a gradient elution consisting of ACN (eluent A) and
aqueous 0.2% acetic acid (eluent B) at a ﬂow rate of
300μL/min. The gradient patternwassimilar tothatusedfor
LC/PDA analysis. The HPLC elution after PDA was analyzed
by the mass spectrometer (MS) using electrospray ionization
(ESI). All analyses were performed using an ESI interface
with the following settings: positive ionization mode; the
capillary temperature was set at 250◦C; spray voltage was set
at4.5kV;capillaryvoltagewassetat6V;sheathgas(N2)ﬂo w
wasﬁxedat30AU;auxiliarygas(N2)ﬂowwasﬁx edat10A U .
3. Results and Discussion
3.1. Chromatographic Peaks Identiﬁcation. In the prelimi-
nary study, hypocholesterolemic activity in the fermented
products using M. purpureus FTC5391 was analysed in
vivo via animal testing. Hypocholesterolemic activity was
detected in all MFPs tested, and it was assumed due to the
existence of monacolins (unpublished data). In this study,
the existence of monacolins in similar MFPs was evaluated
using LC/PDA/MS.
Basically, diﬀerent derivatives of monacolins have similar
structures, and consequently, similar UV spectra. In this
study, diﬀerent concentrations of MKA and MKL standards
were prepared and analyzed via LC/PDA/MS. Figure 1 shows
the chromatogram and UV spectrum of the MK standard.
The retention time (RT) of MKL and MKA were observed at
21min and 17min, respectively. The UV spectrum of MKL
and MKA showed a pattern with three λmax at 232, 239,
and 248nm. The chromatograms of Hypocol (Figure 2)a n d
RYR (Figure 3) showed 12 and 3 extra peaks, respectively,
with a similar UV spectrum pattern of MK. These extra
peaks may be related to other derivatives of monacolin
due to existence of similarities in their structures (common
polyketide portion, a hydroxy-hexahydro-naphthalene ring
system, where diﬀerent side chains are attached).
The chromatogram results of all MFPs produced using
M. purpureus FTC5391 by two diﬀerent methods of fermen-
tation (SSF and SmF) with various substrates showed that
there was only one peak with the same RT as MK standard,
while its UV spectrum was diﬀerent. The UV spectrum of
this peak showed the λmax at 228nm and that was not similar
with UV spectrum of mountain-like peak at λmax of 232,
239, and 248nm (Figure 4). This means that all MFPs using
M. purpureus FTC5391, tested in this study, did not contain
monacolin derivatives. The UV spectrum peak at RT of
11.917min was similar to yellow pigment spectrum [8]w i t h
λmax pattern at 237, 280, and 332nm (Figure 4).
LC/MS is one of the informative methods for the
detection and identiﬁcation of the bioactive molecules.
Recently, rp-HPLC has been widely applied for the deter-
mination of secondary metabolites in MFP such as pig-
ments, monacolins, GABA, and several other components
[8, 9, 17–19]. Improvement of the technical performance
of chromatography permits eﬃcient separation of similar
molecules. Adjustment and selection of the mobile phase is
one of most important stages of analyses in the rp-HPLC.
Although a large variety of organic solvents can be used in
reversed phase chromatography, in practice only a few are
routinely employed. Acetonitrile and methanol are the most4 Journal of Biomedicine and Biotechnology
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Figure 1: HPLC chromatogram proﬁle with UV spectra of monacolin K standard. (a) Monacolin K lactone form (MKL) chromatogram,
and (b) monacolin K acid form (MKA) chromatogram.
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Figure 2: HPLC chromatogram of the supplement-fermented Monascus purpureus Hypocol. (a) Hypocol HPLC chromatogram proﬁle
before lactonization and (b) after lactonization.
c o m m o n l yu s e ds o l v e n t si nt h i sc a s e ,s i n c eb o t hh a v el o wvi s -
cosity(evenwhenmixedwithaqueoussolutions)andareUV
transparent. Reverse phase separations are most often per-
formed at low pH values, generally between pH 2 to 4. The
low pH results in good solubility of the sample components
and ion suppression, not only of acidic groups on the sample
molecules, but also of residual silanol groups on the silica
matrix. Acids such as triﬂuoroacetic acid, heptaﬂuorobutyric
acid, and orthophosphoric acid in the concentration range
of 0.05–0.1% would be suitable in this type of separation.
Hence, triﬂuoroacetic acid (0.1%) and concentrated acetoni-
trile were used in this study as the mobile phase.
3.2. Conﬁrmation of Monacolin K Identiﬁcation
3.2.1. Lactonization. Monacolin molecules exist in two
f o r m so fl a c t o n ea n dh y d r o x y la c i d[ 15]. Lactonization or
alkalization of monacolins was performed by mixing the
sample with NaOH before applying to LC/PDA system.
Alkalization of MK standard caused a shift in the RRT
from 21min to 17min without changing the UV spectrum,
indicating that both peaks have similar molecular structures
(Figure 1), where it was in agreement with the previous
report [20]. Comparison between two chromatograms of
pre- and postalkalized Hypocol, RYR, and MFP FTC5391
extracts (Figures 2, 3 and 4, resp.) revealed that some peaks
disappeared, while some new peaks appeared. In addition,
after alkalization some peak areas increased. However, the
similarity of UV spectra of the missed peaks and those
with the increased peak areas was high. Although the typical
chromatogramforMFPusingM.purpureusFTC5391extract
before and after lactonization did not change (Figure 4),
the comparison between Hypocol and RYR chromatograms
and their UV spectra before and after lactonization showed
some diﬀerences (Figures 2 and 3). The RYR chromatogram
(Figure 3) showed a large peak in the RT of 21min before
lactonization, this peak shifted to 17min after lactonization
with similar spectrum of MKL. After the shifted of large
peak, a small peak at the RT of 21min appeared with
diﬀerent UV spectrum of MKL. This peak showed a similar
UV spectrum with the peak for MFP using M. purpureus
FTC5391 extract at RT of 21min. In addition, the Hypocol
chromatogram demonstrated a small peak in the RT of
17min that grew up after lactonization. These results
suggested that there were two diﬀerent peaks belonging to
diﬀerent compounds, where the small peak was masked by
the large peak in the same RT. However, lactonization shifted
the MKL peak and helped to reveal the concealed peak.
Additional MK standard solution in MFP using M.
purpureus FTC5391 extract was employed to conﬁrm the
existence of MK. Figure 5 shows that the addition of MK
standard reproduced the peak at RT of 21min in the MFPJournal of Biomedicine and Biotechnology 5
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Figure 3: HPLC chromatogram with UV spectra of the supplement-fermented Monascus purpureus RYR (commercial product). (a) RYR
HPLC chromatogram proﬁle with UV spectrum before lactonization and (b) after lactonization. MKL: monacolin K lactone form, MKA:
monacolin K acid form.
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Figure 4: A typical HPLC chromatogram proﬁle with UV spectra of MFP using Monascus purpureus (FTC5391). (a) Chromatogram before
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monacolin K lactone form, MKA: monacolin K acid form.
chromatogram. Moreover, there was a signiﬁcant diﬀerence
in comparison between the UV spectra related to peaks at
RT of 21min in pre- and postmixing of the MK standard
solution with MFP extract. The premixing UV spectrum
associated with the peak at RT of 21min showed λmax at
228nm, while the postmixing UV spectrum transformed to
the MK spectrum shape with three λmax at 232, 239, and
248nm. The chromatogram of MFP using M. purpureus
FTC5391 extract blended with MK standard solution after
lactonization showed the appearance of a peak at RT 17,
where the peak area at RT 21 decreased and its UV spectrum
also changed. These results doubly conﬁrmed the existence
of two diﬀerent coincided peaks in the same RT, those
concealed each other. Therefore, it was concluded that all
MFPs produced using FTC5391 M. purpureus FTC5391,
tested in this study, did not contain MK.
It is interesting to note that the conversion of monacolins
from the lactone form to acid form is a special clue for the
development of simple and rapid method for monacolins
detection via LC/PDA/MS. In fact, RT evaluation alone is
not enough for the identiﬁcation of bioactive compounds
by the LC/PDA method. Thus, this method should be
utilized with the examination of other special properties of
the target molecule simultaneously. In these cases, where
there are two or more compounds with the same RT in
the sample, the peaks cover each other and the compound
with the higher amount may dominate and mask the other
molecules. For a case where the small peaks were related to
monacolin, a step of lactonization of monacolins must be
added in the detection procedure of LC/PDA/MS to enable
identiﬁcation.
3.3. Identiﬁcation of Monacolins by LC/PDA/MS. For further
identiﬁcation of the existence of monacolins in the samples
and to complete the monacolins identiﬁcation, all samples
and standard solutions were traced by hyphenated instru-
mentation of LC-MS. The quadruple ion trap mass analyzer
serves to store, fragment in, and select ions for detection.
Therefore, the total ion current (TIC) chromatogram, mass,
UV spectra, and selective ion chromatograms (SIC) for each
peak were evaluated, one by one. The results conﬁrmed the
existence of MKL, MKA, MJA, MJ, MXA, MLA, MX, MKA,
ML, P1, MMA, MM, and DMK in Hypocol; MKL, MM, and
DMK in RYR.
The molecular ion chromatograms and mass spectra
patterns for MKL and MKA STD by the LC/PDA/MS6 Journal of Biomedicine and Biotechnology
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showed the predominant peaks at RT around 15.82min and
11.82min; λmax at 245nm; mass spectrum 405 (M + 1) and
423 (M + 1), respectively. The LC/PDA/MS chromatograms
of standards (MKL and MKA) in comparison to MFP using
M. purpureus FTC5391, Hypocol, and RYR chromatograms
revealed that the Hypocol included both MKL and MKA,
whereas RYR included only MKL, and the MFP using M.
purpureus FTC5391 tested had no monacolins, not even MK.
Figures 6 and 7 show the diﬀerences between mass spectra
of MK standard and MFP using M. purpureus FTC5391
compound with similar RT of MK.
3.4. Eﬀect of Fermentation Conditions on MK Production.
Production of monacolins, secondary metabolites, is inﬂu-
enced by physicochemical factors of the fermentation condi-
tions and is strain-dependent based on individual abilities of
the microorganisms [21–25]. Therefore, manipulation of the
fermentation conditions (temperature, aeration, nutritional
factors, as well as fermentation method) is necessary to
induce or enhance the ability of M. purpureus strains to
secrete monacolins. Results from this study indicated that
the use of two types of fermentation methods (SmF and
SSF) with various medium formulations and fermentation
conditions did not induce monacolins production by M.
purpureus FTC5391.
Comparison between HPLC chromatogram proﬁles of
HypocolandRYRrevealedthattheUVspectraandthenum-
ber of chromatogram peaks were not similar even though
both extracts were derived from MFPs using M. purpureus
FTC5391 (Figures 2 and 3). Hypocol chromatogram showed
the existence of MKL, MKA, and several other peaks with
MK-like UV spectra, while the RYR chromatogram revealed
just the existence of MKL and a few numbers of peaks with
MK-like UV spectra. Since the supplements tested in this
study were produced by the diﬀerent companies under
diﬀerent fermentation conditions using diﬀerent strains of
M. purpureus, some of the metabolites or all of them may
not be existed in the products. This is in agreement with the
results for the analysis of citrinin; and the lactone acid forms
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Figure 7: A typical MS chromatogram proﬁle of MFP using M. purpureus FTC5391, which also highlighting the compound with similar
RT of MKL standard. (a) MS chromatogram, (b) MS spectrum of compound with similar RT of MKL standard. The MFP was produced by
submerged fermentation using Hiroi-PDA (sucrose (100g/L), yeast extract (3g/L), casamino acid (5g/L), NaNO3 (2g/L), KH2PO4 (1g/L),
MgSO4·7H2O (0.5g/L), KCl (0.5g/L), FeSO4 (0.01g/L), potato starch (4g/L), dextrose (20g/L), and agar (15g/L)).
3.5.EﬀectofDiﬀerentSolventsonMonacolinsExtractionQual-
ity. Extraction of the monacolins is the ﬁrst step required for
detection and identiﬁcation. Selection of appropriate solvent
is important to maximize the eﬃciency of the extraction.
MK is soluble in methanol, ethanol, acetone, chloroform
and benzene but not in n-hexane and petroleum ether [15].
Moreover, ethyl acetate has been used for the extraction of
MK [27]. The ability of several polar and nonpolar organic
solvents (log P values: −0.76 to 0.8) to dissolve MK for
the enhancement of the extraction of MK from Hypocol
is shown in Table 1. The following sequence for solubility
strength of solvents was achieved to dissolve the MK:
Methanol > Ethanol > Isopropanol > Acetonitrile >
Ethyl acetate > Butanol
The peaks pattern (MK-like-spectra) from the HPLC chro-
matograms was as follows (the numbers in parentheses
indicate the numbers of peaks):
Methanol (18) > Ethanol (17) > Acetonitrile (15) >
Isopropanol (14) > Butanol (12) > Ethyl acetate(9)
Methanol and ethanol were identiﬁed as the preferred
solvents for monacolins extraction due to their ability to
extract the highest amount of MKL and the highest numbers
of monacolin derivatives. In accordance with these results,
Lee et al. [26] also reported that ethanol and methanol were
the preferred extraction solvents for MKL, while ethanol was
suggested as the best solvent to extract citrinin, MKL, and
MKA. Methanolic and ethanolic Hypocol extracts included
about 17 and 18 peaks, respectively, which were similar to
the UV spectrum of MKL (mountain-like peak at λmax of
232, 239, and 248nm). The solvents that could dissolve the
MK were in a range of semipolar to nonpolar. In spite of no
Table 1: The eﬃciency of diﬀerent solvents on quantity of
monacolin K and quality of monacolins.
Solvents Log P value
Number of peaks with
similar UV spectrum of
MK
Amount of
MK extracted
(mg/mL)
Methanol −0.76 18 0.046
Ethanol −0.31 17 0.044
Acetonitril −0.34 15 0.044
Isopropanol 0.05 14 0.024
Butanol 0.8 12 0.0072
Ethyl acetate 0.7 9 0.002
clearcorrelationbetweenlogP valuesoforganicsolventsand
the solubility of monacolins, results of this study indicated
that the nonpolar solvents were the preferred solvents for
monacolins extraction. The highest extraction eﬃciency was
obtained by methanol (log P value of −0.76). Moreover,
mixing a proper quantity of water to the water miscible
solvents or powder (solid) samples increased the dissolving
ability of the target compounds. The diluted solvent could
diﬀuse better in the sample and, consequently, promoted the
extraction of monacolins from the base material. Therefore,
methanol, ethanol, and isopropanol, as water miscible
solvents, were preferred for monacolins extraction from
Monascus-fermented product prepared through SSF.
3.6. Eﬀect of Physical Factors on Monacolins Extraction
Quantity. One of the eﬀective methods for improving the
extraction of thermostable compounds is heating. Since
MK is a thermostable molecule (mp=157–159◦C) [15],
it was predictable that heating enhanced the amount of8 Journal of Biomedicine and Biotechnology
MK extraction. The performance of MK extraction was
also evaluated under diﬀerent temperatures (37◦C–80◦C)
for 30min, 1h, 2h, and 12h. The results showed that the
extraction performance was increased up to 60◦Cf o r2 h
and decreased beyond this temperature. Extension of the
extraction time beyond 2h did not further improve the
extractionperformanceofthetargetcompound.Inaddition,
agitation also signiﬁcantly improved monacolins extraction.
As a conclusion, the optimum conditions for MK extraction
was a mixture of sample with ethanol and water (75:25) at
60◦C for 2h under shaking conditions for SSF and a mixture
of concentrated ethanol with sample (1:1 v/v) for the SmF
under shaking conditions at 60◦Cf o r2h .
4. Conclusions
Results from this study have demonstrated the uniqueness
of HPLC chromatograms and UV spectrum proﬁles for the
identiﬁcation and quantiﬁcation of monacolins in the fer-
mented products of M. purpureus. Monacolins lactonization
was found to be the important property of monacolins
that can be used to solve the problem of false-positive
results in monacolin identiﬁcation and quantiﬁcation using
LC/PDA/MS. The methanolic extraction of MFP using M.
purpureus FTC5391 pulled 18 compounds with a similar UV
spectrum to MK was observed in this study, though the
existence of 14 derivatives of monacolins has been reported
to date. Using this improved technique, monacolin was not
detected in all MFPs tested in this study (produced by M.
purpureus FTC5391 using diﬀerent fermentation techniques
and substrates). The hypocholesterolemic activity of the
MFPs using M. purpureus FTC5391 may be due to the
present of other compounds aside from monacolins with
hypocholesterolemic eﬀects. Future study is necessary to
identify the substance(s) that are responsible for this activity
and the underlying molecular mechanisms involved.
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